Positron emission tomography in lung cancer

Ann Thorac Surg. 1998 Jun;65(6):1821-9. doi: 10.1016/s0003-4975(98)00106-4.

Abstract

Reports on positron emission tomography have become more common in the oncology literature. After a short introduction to positron emission tomography, this review will look at the data relating to the use of this technology in the diagnosis, the staging, and the post-treatment evaluation of patients with lung cancer and will discuss its potential role in these evaluations.

Publication types

  • Review

MeSH terms

  • Carcinoma, Bronchogenic / diagnostic imaging
  • Carcinoma, Bronchogenic / pathology
  • Carcinoma, Bronchogenic / secondary
  • Carcinoma, Bronchogenic / therapy
  • False Negative Reactions
  • Fluorodeoxyglucose F18
  • Humans
  • Lung / abnormalities
  • Lung / diagnostic imaging
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy
  • Lymphatic Metastasis / diagnostic imaging
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Staging
  • Radiopharmaceuticals
  • Tomography, Emission-Computed*
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18